Publications by Dr Max Robinson - ePrints

Browsing publications by Dr Max Robinson.

Newcastle Authors	Title	Year
Dr Max Robinson	A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma	2022
Dr Hans Sathasivam Professor Philip Sloan Professor Peter Thomson Dr Max Robinson	The clinical utility of contemporary oral epithelial dysplasia grading systems	2022
Dr Max Robinson	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer	2021
Dr Hans Sathasivam Dr Ralf Kist Professor Philip Sloan Professor Peter Thomson Michael Nugent et al.	Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology	2021
Richard Walton Dr Max Robinson Professor Marco Carrozzo	A service evaluation of the diagnostic testing for mucous membrane pemphigoid in a UK Oral Medicine Unit	2020
Dr Hans Sathasivam John Casement Professor Philip Sloan Dr Max Robinson Dr Ralf Kist et al.	Gene expression changes associated with malignant transformation of oral potentially malignant disorders	2020
Dr Hans Sathasivam Professor Philip Sloan Dr Ralf Kist Dr Max Robinson	Prognostic Classifier for Oral Potentially Malignant Disorders: An Integrated Histopathological and Molecular approach	2019
Dr Max Robinson Nick West	Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work	2019
Dr Max Robinson	Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach	2019
Dr Max Robinson Professor Philip Sloan	The use of digital pathology and image analysis in clinical trials	2019
Dr Max Robinson Professor Philip Sloan Dr Andrew Hall	Training and accreditation standards for pathologists undertaking clinical trial work	2019
Dr Hans Sathasivam Benjamin Cosway Professor Vinidh Paleri Matt Kennedy Dr Rachel Pearson et al.	Clinicopathological features of squamous cell carcinoma of the oral cavity and oropharynx in young patients	2018
Dr Hans Sathasivam Paula Bradley Professor Vinidh Paleri Professor Philip Sloan Dr Max Robinson et al.	Concurrent HPV-related oropharyngeal carcinoma in four couples	2018
Dr Max Robinson	Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams)	2018
Dr Timothy Bates Professor Jeffrey Pearson Dr Max Robinson Jason Powell	Laryngeal candidiasis: our experience from sixty biopsy specimens	2018
Dr Max Robinson	Predictors of oropharyngeal cancer survival in Europe	2018
Dr Max Robinson	Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial	2018
Dr Hans Sathasivam James O'Hara Dr David Meikle Dr Charles Kelly Dr Max Robinson et al.	Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer	2018
Professor Vinidh Paleri Dr David Meikle James O'Hara Dr Max Robinson	Transoral robotic surgery for residual and recurrent oropharyngeal cancers: Exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies	2018
Dr Max Robinson	HPV testing of head and neck cancer in clinical practice	2017
Dr Max Robinson	PET-NECK: A multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer	2017
Dr Timothy Bates Dr Michaela Goodson Professor Peter Thomson Professor Philip Sloan Dr Ralf Kist et al.	Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis	2016
Professor Peter Thomson Dr Max Robinson	Combined effects of smoking and HPV16 in oropharyngeal cancer	2016
Dr Max Robinson	Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer	2016
Dr Max Robinson Professor Vinidh Paleri	Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials.	2016
Dr Max Robinson	HOPX functions as a tumour suppressor in head and neck cancer	2016
Dr Max Robinson Professor Philip Sloan	HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology	2016
Dr Max Robinson	Intraoperative sentinel lymph node evaluation: implications of cytokeratin 19 expression for the adoption of OSNA in oral squamous cell carcinoma	2016
Dr Max Robinson	Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines	2016
Dr Max Robinson Professor Philip Sloan	Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines	2016
Dr Max Robinson	Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx	2016
Dr Max Robinson	PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer	2016
Dr Max Robinson	PREDICTR Study: Biomarkers in Oro-Pharyngeal Squamous Cell Carcinoma	2016
Michael Nugent Dr Max Robinson	Should we test for high-risk human papilloma virus in patients with oral dysplasia?	2016
Dr Max Robinson	Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach	2016
Dr Max Robinson	Human papillomavirus testing in diagnostic head and neck pathology	2015
Dr Max Robinson	IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer	2015
Robert Banks Dr Max Robinson	Juvenile xanthogranuloma: unusual intraoral finding	2015
Professor Vinidh Paleri Dr Max Robinson	Multicentric human papillomavirus-associated head and neck squamous cell carcinoma	2015
Dr Michaela Goodson Professor Philip Sloan Dr Max Robinson Professor Peter Thomson	Oral precursor lesions and malignant transformation - who, where, what, and when?	2015
Dr Joanne Patterson Dr Max Robinson	PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer	2015
Dr Max Robinson	PET-NECK: A multi-centre, randomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT)	2015
Anne Chambers Dr Max Robinson Robert Banks Professor Philip Sloan	Twenty-first-century oral hairy leukoplakia-a non-HIV-associated entity	2015
Dr Max Robinson	Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma: Best Practice for Diagnosis	2014
Professor Vinidh Paleri Dr Max Robinson	Patients with HPV-related tonsil squamous cell carcinoma rarely harbour oncogenic HPV infection at other pharyngeal sites	2014
Dr Timothy Bates Professor Peter Thomson Professor Philip Sloan Dr Max Robinson Dr Ralf Kist et al.	PAX9 expression in potentially malignant disorders and early stage squamous carcinoma of the oral cavity	2014
Dr Timothy Bates Dr Max Robinson	Small Cell Neuroendocrine Carcinoma of the Oropharynx Harbouring Oncogenic HPV-Infection	2014
Professor Philip Sloan Dr Max Robinson	Squamous Cell Carcinoma of the Head and Neck Outside the Oropharynx Is Rarely Human Papillomavirus Related	2014
Dr Ralf Kist Michelle Watson Moira Crosier Dr Max Robinson Dr Julia Reichelt et al.	The Formation of Endoderm-Derived Taste Sensory Organs Requires a Pax9-Dependent Expansion of Embryonic Taste Bud Progenitor Cells	2014
Dr Ameena Diajil Dr Max Robinson Professor Philip Sloan Professor Peter Thomson	Clinical Outcome Following Oral Potentially Malignant Disorder Treatment: A 100 Patient Cohort Study	2013
Dr Max Robinson	Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population	2013
Dr Max Robinson Professor Vinidh Paleri	Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population	2013
Dr Max Robinson Professor Vinidh Paleri	Salivary gland swellings	2013
Dr Michael Drinnan Dr Max Robinson Dr David Meikle Andrew Welch Dr Ivan Zammit-Maempel et al.	Thyroid gland invasion in total laryngectomy and total laryngopharyngectomy: a systematic review and meta-analysis of the English literature	2013
Professor Philip Sloan Dr Max Robinson	Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma	2013
Dr Max Robinson	Detection of Oncogenic Human Papillomavirus in Nasopharyngeal Carcinoma	2012
Dr Timothy Bates Dr Tuomo Polvikoski Professor Philip Sloan Dr David Meikle Dr Max Robinson et al.	Ganglioneuroblastic transformation in olfactory neuroblastoma	2012
Dr Max Robinson Professor Philip Sloan	HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients	2012
Dr Max Robinson Professor Vinidh Paleri	Salivary gland swellings	2012
Dr Max Robinson	The Pathology of Virus-Related Carcinomas of the Upper Aerodigestive Tract	2012
Professor Philip Sloan Dr Max Robinson	Validation for a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma.	2012
Dr Max Robinson Professor Philip Sloan	Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity and prognostic discrimination	2011
Professor Philip Sloan Dr Max Robinson	Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice	2011
Dr Christine Challen Professor Philip Sloan Professor Mark Birch-Machin Dr Max Robinson	Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility	2011
Dr Max Robinson	Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus	2011
Robert Shaw Dr Max Robinson	The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer	2011
Dr Max Robinson Professor Philip Sloan	CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions	2010
Dr Max Robinson Professor Philip Sloan	Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing	2010
Dr Max Robinson	Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation	2009
Professor Vinidh Paleri Dr Max Robinson	Polymorphous low-grade adenocarcinoma of the head and neck	2008
Dr Max Robinson	Expression of Ki-67 and p53 in cutaneous free flaps used to reconstruct soft tissue defects following resection of oral squamous cell carcinoma	2007
Dr Max Robinson	Spindle assembly checkpoint and centrosome abnormalities in oral cancer	2007
Dr Max Robinson	An investigation into the practice of tongue piercing in the South West of England	2006
Dr Max Robinson	Lichenoid and granulomatous stomatitis: an entity or a non-specific inflammatory process?	2006
Dr Max Robinson	Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways	2005
Dr Max Robinson	Attenuated type II TGF-β receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination	2004
Dr Max Robinson	Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-β1	2004
Dr Max Robinson	A study of the clinical characteristics of benign trigeminal sensory neuropathy	2003
Dr Max Robinson	Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines	2003
Dr Max Robinson	TGF-β1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G1 arrest	2002
Dr Max Robinson	Decreased expression of TGF-β cell surface receptors during progression of human oral squamous cell carcinoma	2001
Dr Max Robinson	Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation	2001
Dr Max Robinson	Oral Psoriasis	1996